Teva’s Aziltec drug was proven to be effective, safe and well tolerated in one of the largest ever studies conducted on the Parkinson’s disease. The ADAGIO study covered 1,176 patients with early Parkinson's at 129 centers in 14 countries over a period of 18 months. These results could turn Aziltec into a "disease modification" labeled drug.
read more | digg story
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment